Retraction: EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines

Source: Molecular Cancer Therapeutics - Category: Cancer & Oncology Tags: Retraction Source Type: research